BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18708158)

  • 1. Apoptosis of metastatic prostate cancer cells by a combination of cyclin-dependent kinase and AKT inhibitors.
    Mohapatra S; Chu B; Zhao X; Djeu J; Cheng JQ; Pledger WJ
    Int J Biochem Cell Biol; 2009 Mar; 41(3):595-602. PubMed ID: 18708158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells.
    Mohapatra S; Chu B; Zhao X; Pledger WJ
    Cancer Res; 2005 Sep; 65(17):7717-23. PubMed ID: 16140939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process.
    Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S
    Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prometaphase arrest-dependent phosphorylation of Bcl-2 and Bim reduces the association of Bcl-2 with Bak or Bim, provoking Bak activation and mitochondrial apoptosis in nocodazole-treated Jurkat T cells.
    Han CR; Jun do Y; Lee JY; Kim YH
    Apoptosis; 2014 Jan; 19(1):224-40. PubMed ID: 24166139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18β-glycyrrhetinic acid induces apoptosis through modulation of Akt/FOXO3a/Bim pathway in human breast cancer MCF-7 cells.
    Sharma G; Kar S; Palit S; Das PK
    J Cell Physiol; 2012 May; 227(5):1923-31. PubMed ID: 21732363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk inhibitors, roscovitine and olomoucine, synergize with farnesyltransferase inhibitor (FTI) to induce efficient apoptosis of human cancer cell lines.
    Edamatsu H; Gau CL; Nemoto T; Guo L; Tamanoi F
    Oncogene; 2000 Jun; 19(27):3059-68. PubMed ID: 10871858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
    Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
    Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells.
    Gillespie S; Borrow J; Zhang XD; Hersey P
    Apoptosis; 2006 Dec; 11(12):2251-65. PubMed ID: 17051334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bim(L) displacing Bcl-x(L) promotes Bax translocation during TNFalpha-induced apoptosis.
    Zhang L; Xing D; Chen M
    Apoptosis; 2008 Jul; 13(7):950-8. PubMed ID: 18500555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
    Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
    Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
    Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin.
    Lim DY; Park JH
    Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1060-8. PubMed ID: 19264955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the lethality of the histone deacetylase inhibitor LAQ824 by the cyclin-dependent kinase inhibitor roscovitine in human leukemia cells.
    Rosato RR; Almenara JA; Maggio SC; Atadja P; Craig R; Vrana J; Dent P; Grant S
    Mol Cancer Ther; 2005 Nov; 4(11):1772-85. PubMed ID: 16275999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
    Pfeil K; Eder IE; Putz T; Ramoner R; Culig Z; Ueberall F; Bartsch G; Klocker H
    Prostate; 2004 Feb; 58(3):259-68. PubMed ID: 14743465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG
    Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyclin-dependent kinase inhibitor R-roscovitine down-regulates Mcl-1 to override pro-inflammatory signalling and drive neutrophil apoptosis.
    Leitch AE; Riley NA; Sheldrake TA; Festa M; Fox S; Duffin R; Haslett C; Rossi AG
    Eur J Immunol; 2010 Apr; 40(4):1127-38. PubMed ID: 20127676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
    Ray S; Almasan A
    Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shp2E76K mutant confers cytokine-independent survival of TF-1 myeloid cells by up-regulating Bcl-XL.
    Ren Y; Chen Z; Chen L; Woods NT; Reuther GW; Cheng JQ; Wang HG; Wu J
    J Biol Chem; 2007 Dec; 282(50):36463-73. PubMed ID: 17942397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bim directly antagonizes Bcl-xl in doxorubicin-induced prostate cancer cell apoptosis independently of p53.
    Yang MC; Lin RW; Huang SB; Huang SY; Chen WJ; Wang S; Hong YR; Wang C
    Cell Cycle; 2016; 15(3):394-402. PubMed ID: 26694174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smac is required for cytochrome c-induced apoptosis in prostate cancer LNCaP cells.
    Carson JP; Behnam M; Sutton JN; Du C; Wang X; Hunt DF; Weber MJ; Kulik G
    Cancer Res; 2002 Jan; 62(1):18-23. PubMed ID: 11782351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.